trump glp 1 Trump's Plan to Expand Access to Weight-Loss Drugs Just Hit a Major Roadblock Weight-loss drug makers announce pricing

demonstrated the considerable effect of weight loss in healthy subjects and patients with T2DM within only 4 weeks of treatment ( In addition, a phase 3, multicenter, randomized, placebo-controlled study has been performed, in which adults with a BMI greater than 30 kg/m 2 or 27 kg/m 2 with at least one obesity-related complication, except T2DM, were recruited

However, the use of medications for obesity, as for other chronic diseases, will likely require life-long treatment, which makes it important to analyze the long-term efficacy, safety, and economic implications of chronic pharmacotherapy

In clinical studies on weight loss, the highest doses tend to get the spotlight, but lower doses also deliver significant results

doi: 10.3389/fendo.2023.1270115

Hippocampal GLP-1 Receptors Influence Food Intake, Meal Size, and Effort-Based Responding for Food through Volume Transmission

What have you learned about them through your research